Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Medicsen Smartpatch: Safety & Performance (SOUNDD)

NCT: NCT07615959 · ACTIVE_NOT_RECRUITING

NCT IDNCT07615959
StatusACTIVE_NOT_RECRUITING
Start Date2026-01-20
Completion2026-11

Brief Summary

The goal of this clinical trial is to understand the efficacy of Medicsen's Smartpatch to deliver drugs through the skin in healthy volunteers. The main questions it aims to answer are: * Is the administration with Medicsen Smartpatch safe for the patient? * Can Medicsen's Smartpatch be used to effectively administer drugs to patients? Researchers will compare administration with Medicsen's Smartpatch with the subcutaneous administration of the drug to see if the efficacy and safety are comparable Participants will be asked to fill a tolerability survey after receiving each of the two interventions: Subcutaneous administration and Medicse's Smartpatch. Blood samples will be taken at different timepoints to asses for efficacy of each treatment.

Frequently Asked Questions

What is Medicsen Smartpatch: Safety & Performance (SOUNDD)?

Medicsen Smartpatch: Safety & Performance (SOUNDD) is a clinical trial registered under NCT07615959. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07615959?

The current status of NCT07615959 (Medicsen Smartpatch: Safety & Performance (SOUNDD)) is: ACTIVE_NOT_RECRUITING.

When did Medicsen Smartpatch: Safety & Performance (SOUNDD) start?

Medicsen Smartpatch: Safety & Performance (SOUNDD) started on 2026-01-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.